22-50220869-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_020461.4(TUBGCP6):​c.3490G>A​(p.Val1164Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,611,396 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1164A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00020 ( 1 hom. )

Consequence

TUBGCP6
NM_020461.4 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.610

Publications

2 publications found
Variant links:
Genes affected
TUBGCP6 (HGNC:18127): (tubulin gamma complex component 6) The protein encoded by this gene is part of a large multisubunit complex required for microtubule nucleation at the centrosome. [provided by RefSeq, Jul 2008]
TUBGCP6 Gene-Disease associations (from GenCC):
  • microcephaly and chorioretinopathy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007892489).
BP6
Variant 22-50220869-C-T is Benign according to our data. Variant chr22-50220869-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 437147.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00143 (216/150576) while in subpopulation AFR AF = 0.00509 (208/40864). AF 95% confidence interval is 0.00452. There are 0 homozygotes in GnomAd4. There are 98 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBGCP6NM_020461.4 linkc.3490G>A p.Val1164Met missense_variant Exon 16 of 25 ENST00000248846.10 NP_065194.3 Q96RT7-1
TUBGCP6XR_001755343.3 linkn.4054G>A non_coding_transcript_exon_variant Exon 16 of 20
TUBGCP6XR_938347.3 linkn.4054G>A non_coding_transcript_exon_variant Exon 16 of 23
TUBGCP6XR_007067982.1 linkn.3049-854G>A intron_variant Intron 15 of 18

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBGCP6ENST00000248846.10 linkc.3490G>A p.Val1164Met missense_variant Exon 16 of 25 1 NM_020461.4 ENSP00000248846.5 Q96RT7-1
TUBGCP6ENST00000439308.7 linkn.3490G>A non_coding_transcript_exon_variant Exon 16 of 25 1 ENSP00000397387.2 E7EQL8
TUBGCP6ENST00000498611.5 linkn.3617+406G>A intron_variant Intron 16 of 22 1
TUBGCP6ENST00000491449.5 linkn.1797G>A non_coding_transcript_exon_variant Exon 8 of 16 5

Frequencies

GnomAD3 genomes
AF:
0.00143
AC:
215
AN:
150450
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00508
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000198
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000739
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000314
AC:
79
AN:
251420
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.00431
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000197
AC:
288
AN:
1460820
Hom.:
1
Cov.:
38
AF XY:
0.000180
AC XY:
131
AN XY:
726716
show subpopulations
African (AFR)
AF:
0.00634
AC:
212
AN:
33420
American (AMR)
AF:
0.0000898
AC:
4
AN:
44560
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26088
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39638
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86162
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53240
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000360
AC:
40
AN:
1111594
Other (OTH)
AF:
0.000514
AC:
31
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00143
AC:
216
AN:
150576
Hom.:
0
Cov.:
34
AF XY:
0.00133
AC XY:
98
AN XY:
73594
show subpopulations
African (AFR)
AF:
0.00509
AC:
208
AN:
40864
American (AMR)
AF:
0.000198
AC:
3
AN:
15164
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5054
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4726
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10430
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
268
European-Non Finnish (NFE)
AF:
0.0000739
AC:
5
AN:
67616
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000645
Hom.:
0
ESP6500AA
AF:
0.00386
AC:
17
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000420
AC:
51
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 24, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TUBGCP6-related disorder Benign:1
Dec 21, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.025
T;.
Eigen
Benign
-0.046
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.27
N
LIST_S2
Uncertain
0.89
D;D
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.0079
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
0.61
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.3
N;N
REVEL
Benign
0.053
Sift
Benign
0.056
T;D
Sift4G
Uncertain
0.043
D;T
Polyphen
0.82
P;.
Vest4
0.42
MVP
0.31
MPC
0.11
ClinPred
0.032
T
GERP RS
4.6
PromoterAI
-0.033
Neutral
Varity_R
0.038
gMVP
0.29
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9628306; hg19: chr22-50659298; API